CTRI/2023/06/054141
Not yet recruiting
Phase 3
asopharyngeal Airway as an adjunct to reduce Sedation Related Adverse Events during ERCP procedures
Department of GI Anaesthesiology0 sites0 target enrollmentTBD
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Health Condition 1: O- Medical and Surgical
- Sponsor
- Department of GI Anaesthesiology
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. All ASA I and II patients and without major comorbidities undergoing therapeutic ERCP procedure under moderate to deep sedation .
- •2\. Patients who have given written, informed consent to participate in the study.
Exclusion Criteria
- •1\. ASA I and IV patients
- •2\. History of nasal bleed and coagulopathy
- •3\. Cranio facial anomalies
- •4\. Head and face trauma
- •5\. Deviated Nasal Septum or external nasal pathology
- •6\. Major systemic comorbidities
- •7\. Very sick patients
- •8\. Morbid obesity
- •9\. Airway difficulty
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 2
Modified nasopharyngeal airway guidance facilitates nasal fiberoptic intubation: a randomized clinical studyProcedural time and success rate for nasal fiberoptic intubation in a patient aged 18-65 classified by American Society of Anesthesiologists (ASA) physical status 1-3 is scheduled for elective surgery under general anesthesia in Ramathibodi hospitalAirway management, fiberoptic intubation, flexible scope intubation, Flexible bronchoscope, Fiberoptic bronchoscope, nasal intubation, modified nasopharyngeal airway, nasal airwayTCTR20230809006Faculty of Medicine Ramathibodi Hospital, Mahidol University60
Not yet recruiting
Phase 2
Combination Therapies to Reduce Carriage of SARS-Cov-2 and Improve Outcome of COVID-19 in Ivory Coast: a Phase Randomized IIb Trial (INTENSE-COV)COVID-19PACTR202007720062393Inserm ANRS294
Completed
Not Applicable
Treatment by uninterrupted positive airway pressure by nasal route - Evaluation of REMstar® Auto with C-Flex in clinical practiceSleep apnoea/ hypopnoea syndromeNervous System DiseasesSleep disordersISRCTN59353477Respironics International (France)20
Not yet recruiting
Phase 1
Based on reducing airway hyperresponsiveness of children with asthma, observing the clinical effect of adding and subtracting Xingfu Liujunzi Decoction on chronic duratioITMCTR2000004011Yueyang Hospital of Integraced Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine
Completed
Phase 1
Assessment of the routine application of double modified nasopharyngeal airways versus the use of low-flow nasal cannula during pediatric upper gastrointestinal endoscopy.RespiratoryAnaesthesiaPACTR202205629173217Mostafa Mansour Hussein50